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Abstract 
Background: Historically, identification of causal agents of disease has relied heavily on the ability to culture the 
organism in the laboratory and/or the use of pathogen-specific antibodies or sequence-based probes. However, 
these methods can be limiting: Even highly sensitive PCR-based assays must be continually updated due to signature 
degradation as new target strains and near neighbors are sequenced. Thus, there has been a need for assays that 
do not suffer as greatly from these limitations and/or biases. Recent advances in library preparation technologies 
for Next-Generation Sequencing (NGS) are focusing on the use of targeted amplification and targeted enrichment/
capture to ensure that the most highly discriminating regions of the genomes of known targets (organism-unique 
regions and/or regions containing functionally important genes or phylogenetically-discriminating SNPs) will be 
sequenced, regardless of the complex sample background.
Results: In the present study, we have assessed the feasibility of targeted sequence enhancement via amplifica-
tion to facilitate detection of a bacterial pathogen present in low copy numbers in a background of human genomic 
material. Our results indicate that the targeted amplification of signature regions can effectively identify pathogen 
genomic material present in as little as 10 copies per ml in a complex sample. Importantly, the correct species and 
strain calls could be made in amplified samples, while this was not possible in unamplified samples.
Conclusions: The results presented here demonstrate the efficacy of a targeted amplification approach to biothreat 
detection, using multiple highly-discriminative amplicons per biothreat organism that provide redundancy in case of 
variation in some primer regions. Importantly, strain level discrimination was possible at levels of 10 genome equiva-
lents. Similar results could be obtained through use of panels focused on the identification of amplicons targeted for 
specific genes or SNPs instead of, or in addition to, those targeted for specific organisms (ongoing gene-targeting 
work to be reported later). Note that without some form of targeted enhancement, the enormous background 
present in complex clinical and environmental samples makes it highly unlikely that sufficient coverage of key 
pathogen(s) present in the sample will be achieved with current NGS technology to guarantee that the most highly 
discriminating regions will be sequenced.
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Background
Nucleic acid based methods of pathogen detection, such 
as PCR, although robust and sensitive, are often subject 
to false positive and false negative readings. False positive 
errors are often due to detection of a closely related near 
neighbor species, a trend observed with biothreat agents 
[1, 2]. False negative errors are frequently the result of 
levels of target nucleic acid at or below the sensitivity 
threshold [3]. Additionally, strain variation at the nucleo-
tide level can lead to signature erosion. This is especially 
true in organisms with high mutation rates [4]. Although 
PCR-based assays are capable of strain designation, 
this often requires design of multiple primer and probe 
sequences [5]. Additionally, the number of primer pairs 
necessary to detect a large set of organisms or strains is 
often untenable or requires multiple rounds of primer 
design, complex bioinformatic software or both [6].
High-throughput next generation sequencing (NGS) 
has become a viable solution to many of these prob-
lems. Detection of pathogens by NGS is not hampered 
by the constraints discussed above. NGS is relatively 
unbiased, not dependent on specific signature sequence 
information, and requires no a priori knowledge about a 
pathogen. In addition, NGS is culture-independent and 
requires only high-quality nucleic acid. However, NGS is 
not without drawbacks. Until recently, one of the major 
impediments to using NGS for point-of-need (PON) 
detection/diagnostics has been a large amount of time 
(≥7  days) from sample to answer as well as the techni-
cal training and experience necessary to produce qual-
ity sequence reads. In addition, NGS has conventionally 
required nucleic acid masses at least an order of magni-
tude greater than a PCR-based assay. Finally, the labora-
tory space requirements of the sequencer as well as the 
required ancillary equipment often precluded the use of 
NGS by all but the largest research groups.
The advent of benchtop sequencers with easy to use 
and streamlined workflows, such as the Ion Torrent™ 
Personal Genome Machine™, has alleviated many of 
these concerns. A number of recent clinical studies have 
shown the utility of benchtop NGS in identification and 
attribution of disease-causing microorganisms. Spe-
cifically, NGS was used successfully to track nosocomial 
infection of soldiers returning from Afghanistan. In this 
case, standard typing techniques failed to distinguish 
between isolates, while NGS uncovered a number of 
single-nucleotide polymorphisms (SNPs) that allowed 
investigators to establish an epidemiologic chain [7]. 
More recently, using NGS, two groups were simulta-
neously able to identify the causative agent of an out-
break of enterohaemorrhagic Escherichia coli (EHEC) in 
patients in a National Institutes of Health (NIH) clinical 
ward. Another study showed the ability of NGS to rapidly 
and precisely identify outbreak clusters of MRSA and 
Clostridium difficile [8]. However, these studies were per-
formed with clinical isolates of the microbe in question, 
not by metagenomic sequencing of complex primary 
samples.
Multiple studies have documented the difficulties of 
current NGS platforms to yield confident species identi-
fication for microbial agents in complex backgrounds [9, 
10]. Most data to date from these projects indicate that 
the current NGS platforms using unbiased sequencing 
simply do not provide enough pathogen coverage over 
the background to provide even species-level identifi-
cation. Simply put, bench-top NGS cannot sequence 
deeply enough into a complex environmental or clini-
cal trace-level sample to provide even confident species 
identification, much less strain identification or pres-
ence of specific known resistance/virulence factors [11, 
12]. While NGS instruments like the Illumina® HiSeq 
can produce billions of reads, their long run times (i.e. 
>7  days) preclude obtaining actionable information 
quickly enough to guide a response to a public health cri-
sis. Additionally, biases in read coverage result in areas 
of the genome with low, or no coverage, a trend that is 
prominent in AT-rich areas [13]. Finally, a large pro-
portion of unbiased sequence reads will represent the 
‘core genome’ of shared elements found in both patho-
genic and benign organisms of closely related taxa. For 
instance, a study of an important zoonotic pathogen, 
Streptococcus suis, indicated that 876 genes comprised 
a Minimum Core Genome (MCG). Of medical signifi-
cance, only 9 of 21 known virulence genes were shared 
among all strains of this species. Similarly, core genome 
estimates for several other organisms of medical interest 
ranged from 42.7 % (S. pneumoniae) to 15.5 % (H. pylori). 
It is important to note that these studies identified core 
elements of clonal isolates within a species [14, 15]. Thus, 
enhancement strategies that increase our ability to dis-
criminate between closely-related organisms are needed.
There are a number of wet lab methods that aim 
to ameliorate this shortcoming of highly informa-
tive sequence reads. In general, enhancement strate-
gies employ one of two tactics: targeted amplification 
or sequence-based capture enrichment. A familiar and 
widely-employed technique using target amplification is 
16S rRNA gene sequencing [16]. In this approach, uni-
versal primers are used to amplify conserved regions 
of the 16S gene [17]. This method has been utilized in 
numerous studies of bacterial communities (reviewed in 
[18]). Alternatively, investigators have made use of cap-
ture-based enrichment techniques to enrich a sample for 
sequences of interest. In one particular example, samples 
can be depleted of ribosomal RNA using probes bound to 
solid-state supports [19].
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However, these methods are not without limitations. 
Although 16S sequencing is widely accepted and consti-
tutes a current ‘gold standard’ in molecular typing, it has 
low resolution and it has been shown that primer selec-
tion can introduce bias in the resultant amplicons [20]. 
Sequence capture enrichment techniques are subject to 
long hybridization times and generally require probes 
that far exceed the length of PCR primers [21]. Moreo-
ver, the bulk of capture-based enrichment technologies 
have emphasized the human genome (reviewed in [22]) 
rather than microbial pathogens. More recent develop-
ment efforts have focused on use of multiplex PCR prior 
to sequencing. For instance, micro-droplet PCR has been 
shown to enable sequencing of nearly 4000 amplicons 
[23]. A number of studies have evaluated the efficacy of 
multiplex sequencing to characterize human disease as 
well as microbial strain differentiation [24–26]. Specifi-
cally, Life Technologies’ (now Thermo Fisher Scientific) 
Ion AmpliSeq™ technology has been used for human SNP 
typing [25] and detection of genetic variation in human 
cardiomyopathy [26] among others. Ion AmpliSeq™ 
technology currently supports up to 6144 custom primer 
pairs for targeting custom regions. We have utilized the 
Life Technologies Ion AmpliSeq™ robust end-user cus-
tomization capability to support other markets, such as 
pathogen detection, in addition to their standard exon 
and cancer biomarker panels.
Since no commercial panel for biothreat detection 
exists, we sought to design and test a custom AmpliSeq™ 
pilot panel targeting a limited number of microbial 
agents. For this proof of concept study we focused on 
organisms of concern to biodefense and public health, 
specifically microbes from CDC Bioterrorism Tier 1 (B. 
anthracis, Y. pestis, F. tularensis) and Tier 2 (B. pseu-
domallei). In addition to determining the efficacy of our 
custom panel, we investigated the analytical sensitivity of 
the AmpliSeq™ protocol as applied to our mock clinical 
samples.
Results
Comparison of fragment libraries versus AmpliSeq™ 
libraries
In every case, the AmpliSeq™ libraries demonstrated 
a sizable increase in the number of pathogen-specific 
reads with a concomitant reduction in human reads as 
compared to fragment libraries prepared from the same 
samples (Fig. 1). Specifically, the ratio of reads classified 
as human declined from as high as 0.9 in the fragment 
libraries to less than 0.1 in 6 of 8 AmpliSeq™ librar-
ies (Compare 1e3 fragment library with 1e3 AmpliSeq 
library). For each of the four spike-in organisms, we 
noted an increase of at least 1 order of magnitude in 
pathogen reads in the AmpliSeq™ libraries when com-
pared with the corresponding fragment library. This 
Fig. 1 Fraction of reads classified at indicated taxa. Sequence reads resulting from the indicated samples were classified using LMAT with the com-
plete genome database. Numbers are expressed as fraction of the total reads in each particular run. See Additional file 1: Figure S1, Additional file 2: 
Figure S2, Additional file 3: Figure S3, Additional file 4: Figure S4 for organism-specific details
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observation was especially striking in the 1e2 genomic 
equivalents (GE) samples (Additional file  1: Figure S1, 
Additional file  2: Figure S2, Additional file  3: Figure S3, 
Additional file 4: Figure S4). For instance, reads specific 
to B. pseudomallei improved from less than 100 in the 
fragment library to over 10,000 in the AmpliSeq™ library 
(Additional file 2: Figure S2).
Specifically, at a spike-in level of 100 GE for B. pseu-
domallei, the fragment library yielded a total number of 
reads that was at least one order of magnitude less than 
that for the AmpliSeq library (Fig. 2a, b). Although reads 
from the fragment library were spread over both chro-
mosomes, the depth of coverage was low (<10×). In con-
trast, reads from the AmpliSeq libraries were present at 
high coverage levels (>100×). Note that the AmpliSeq™ 
libraries result in species-specific reads distributed 
throughout the genome (Fig. 2a, b).
No reads corresponding to the spike-in organisms 
were present in fragment libraries at a spike-in level of 
less than 100 GE. Importantly, at spike-in levels corre-
sponding to 10 and 1 GE, AmpliSeq™ libraries produced 
informative species-defining reads from all spike-in 
organisms. Conversely, fragment libraries were domi-
nated by the human background. Finally, no sequence 
reads were classified as S. enterica, which served here as a 
negative amplification control.
Further, we observed that read depth was increased by 
orders of magnitude (Fig. 3) and an overwhelming major-
ity of reads from the AmpliSeq™ libraries were able to be 
mapped to the highly-informative amplicons (Table 1). At 
the 1e2 spike level, the T. maritima positive control was 
the largest fraction of classified reads from the fragment 
library (Fig. 1), whereas the largest fraction of classified 
reads from the 1e4 spike fragment library was F. tular-
ensis (Fig. 1). Interestingly, the second largest fraction of 
classified reads in the 1e3 spike samples was T. maritima 
even with a ten-fold increase of GEs versus that for the 
largest fraction, F. tularensis. This trend is also evident in 
1e5 spike and 1e6 spike libraries. This suggests that bias 
exists in one of two steps in the fragment libraries: (1) 
Library construction or (2) Template amplification. There 
is also some preferential amplification evident in the 
AmpliSeq™ libraries as F. tularensis tended to be over-
represented in both the read mapping and taxonomic 
classifications for the lower spike levels. Additional file 1: 
Figure S1, Additional file  2: Figure S2, Additional file  3: 
Figure S3, Additional file 4: Figure S4 show details of the 
reads mapping to B. anthracis, B. pseudomallei, Y. pestis, 
and F. tularensis for all of the unamplified and amplified 
spike-in samples.
It is well known that competition for reagents can 
impact amplification of a given target(s) in multiplex 
Fig. 2 Read mapping against B. pseudomallei K96432 at 1e2 spike-in. a 10,616 reads from an AmpliSeq library mapped to Chromosome 1 of B. pseu-
domallei K96432 (top) compared with 1629 reads from a Fragment library (bottom). b 15,607 reads from an AmpliSeq library mapped to Chromo-
some 2 of B. pseudomallei K96432 (top) compared with 1688 reads from a Fragment library (bottom)
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PCR [27]. In order to investigate the impact of reducing 
the amount of positive amplification control, we created 
and sequenced two samples with T. maritima present 
at the same spike-in level as the organisms of interest 
(1e1Amp_1e1Tmar and 1e0Amp_1e0Tmar). As shown in 
Fig. 1 (far right), the fraction of reads assigned to T. mar-
itma was reduced while the fraction of reads assigned to 
the spike-in organisms was increased. This was especially 
prominent in the samples at a spike in level of 1e1 GEs. 
In each case, the number of reads assigned to the spike-
in organisms increased as compared to the same spike-in 
level containing a greater level of the positive amplifica-
tion control (Additional file 1: Figure S1, Additional file 2: 
Figure S2, Additional file  3: Figure S3, Additional file  4: 
Figure S4). This demonstrates that the amount of positive 
control used may need to be considered depending on 
the desired limit of detection.
Comparison of SNP typing
A common method of confident and reliable phyloge-
netic placement of a sample based on a set of sequence 
reads requires knowledge of single nucleotide polymor-
phisms (SNPs) present at informative loci. Sequence 
reads from all samples were compared to a proprietary 
database of all known SNPs for each spike-in organism, 
based on the multiple genomes available (Table  2). The 
number of SNP loci detected in the High (1e6) Fragment 
and Medium (1e4) Fragment libraries was greater than in 
any of the AmpliSeq™ samples. This is an expected result 
as the fragment libraries at these high concentrations 
(1e6, 1e4) potentially contain the whole genome, while 
the AmpliSeq™ libraries contain a small number of spe-
cifically-targeted loci (Table 3). There is also an expected 
large decrease in the number of SNPs detected at lower 
concentrations in the fragment libraries. Specifically there 
are no SNPs detected for B. pseudomallei or B. anthra-
cis at the 10 GE level. In contrast, for AmpliSeq™ librar-
ies, some loci are detected even at the very lowest spike 
in levels. The “predicted amplicons” in Table  2 indicates 
the theoretical maximum number of known SNP loci that 
should be covered in the AmpliSeq™ samples if exactly 
the predicted amplicons were sequenced. The point being 
Fig. 3 Read mapping against a representative amplicon from B. pseudomallei at 1e2 spike-in. (a), A single read resulting from a fragment library was 
mapped to the amplicon whereas in (b), 1367 reads from the corresponding AmpliSeq™ library were mapped to the same sequence. Areas of differ-
ent color indicate base difference from the reference. Blue cytosine, Red adenine, Green thymine, Yellow guanine
Table 1 Summary of  read mapping to  organism-specific 







1e6 Frag 1,000,000 7172 0.2
1e6 Amp 1,000,000 5,261,163 95.7
1e4 Frag 10,000 1338 0.02
1e4 Amp 10,000 5,781,522 97.7
1e3 Frag 1000 1021 0.01
1e3 Amp 1000 5,037,307 97.6
1e2 Frag 100 12,702 0.2
1e2 Amp 100 5,194,177 96.3
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made here is that the preferential amplification of these 
regions is what allows those known phylogenetically-
informative SNP loci to be interrogated even at the low-
est spike-in levels. Additional apparent SNPs could result 
from errors in the amplification or sequencing, or actual 
differences between the material spiked in and the asso-
ciated reference genome. Polymorphisms and structural 
changes are known to occur in clonal populations [28].
The reads cluster with the correct strain for B. pseu-
domallei and F. tularensis for all the samples with 
detected SNPs. However, this was not observed for 
Y. pestis or B. anthracis. This is likely due to the small 
number of SNPs present by chance in the amplicons 
chosen for identification of these organisms (33 and 34, 
respectively).
In general, neither fragment libraries nor AmpliSeq™ 
libraries reliably cluster with the correct strain (Addi-
tional file 5: Figure S5, Additional file 6: Figure S6, Addi-
tional file  7: Figure S7, Additional file  8: Figure S8). It 
should be noted that primers pairs were not designed to 
cover phylogenetically informative SNPs (although such 
targeting is of course possible). Rather, selected regions 
were chosen to be conserved at the species level. How-
ever, as concentrations drop, reliable SNP interrogation is 
possible only with the AmpliSeq™ libraries (Table 2).
Discussion
These data demonstrate the difficulty involved in obtain-
ing confident bacterial species identification from a 
complex mock human clinical sample via unbiased 
metagenomic sequencing. Employing targeted amplifica-
tion provides a large increase in reads from the discrimi-
nating regions, allowing confident species identification 
to be made at very low spike-in levels. This demonstrates 
that a clear distinction needs to be made between the use 
of NGS as a novel discovery platform (where deep unbi-
ased sequencing must be performed) and as a detector of 
known organisms/genes/SNPs (e.g., comparing against 
reference genome sequence information already available 
in databases).
The use of current benchtop NGS to confidently detect 
a panel of known pathogens at clinical or trace level in 
human or environmental samples will need to employ 
some effective form of background clutter mitigation, 
target capture (via microarray or other enrichment 
approaches), targeted amplification, or a combination of 
strategies. Dependence solely upon unbiased metagen-
omic benchtop sequencing will otherwise lack confi-
dence that accurate species identification can be made 
of the known organisms that may be present at low lev-
els. It should be noted that confident identification of 
important functional genes (e.g., critical anti-microbial 
Table 2 Number of aggregate SNPs in each sample by organism
Sample B. anthracis B. pseudomallei F. tularensis Y. pestis
1e6Frag 673 35,871 22,930 541
1e4Frag 354 9725 5542 372
1e3Frag 65 1403 3520 97
1e2Frag 18 135 82 15
1e1Frag 0 0 11 15
1e6Amp 109 2253 267 54
1e4Amp 45 1367 195 19
1e3Amp 30 1133 141 15
1e2Amp 32 963 166 13
1e1Amp 34 1030 155 16
1e0Amp 17 455 110 4
1e1Amp_1e1Tmar 34 950 147 13
1e0Amp_1e0Tmar 11 338 107 2
Total SNPs/genome 10,004 1,024,037 98,629 8934
Predicted SNPs 33 791 122 34







Yersinia pestis 1,000,000 99
Francisella tularensis 1,000,000 24
Bacillus anthracis 1,000,000 66
Burkholderia mallei 0 5
Burkholderia pseudomallei 1,000,000 124
Salmonella enterica 0 46
Thermotoga maritima 10,000 50
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resistance or virulence factors) cannot be achieved with 
current benchtop NGS for many types of metagenomic 
clinical samples [11] (other than relatively noncomplex 
clinical samples such as cerebrospinal fluid or urine, for 
which antimicrobial resistance prediction from unbiased 
NGS is more reasonable [29]). Without specific target-
ing for pathogens present at clinically-relevant levels and 
with 3000+ genes in a typical bacterium, the odds of the 
small set of unbiased reads that map to the pathogen hit-
ting the handful of critical resistance or virulence genes 
are extremely low.
Although host removal techniques have been devel-
oped for rRNA, the more generalized concept of clut-
ter mitigation has yet to be proven feasible for complex 
environmental samples. One such technique, Selective 
Whole Genome Amplification (SWGA), employs prim-
ers specific to a genome(s) of interest [30]. In principle, 
this technique is similar to the approach presented here. 
Although SWGA would produce sequence reads with 
broader coverage of the target genome, it has not yet 
been shown to be feasible for more than one genome. 
Additionally, methods for removal of host gDNA are still 
in development or are not yet proven to be efficacious in 
complex, metagenomic samples [31, 32]. This leaves cap-
ture enrichment techniques as the leading viable alterna-
tive to targeted amplification [33]. Array or bead-based 
capture enrichment [34] can employ sufficient probes 
to cover all the amplicons used in a targeted amplifica-
tion panel; furthermore, capture approaches, in general, 
can scale much larger than current primer-based ampli-
fication panels available commercially [35]. The tradeoffs 
between the enrichment approaches center on factors 
such as limit of detection (large-scale capture enrichment 
arrays typically rely on some form of random amplifi-
cation), the hybridization time required for capture at 
low levels, and the added cost of the capture step to the 
library prep process (Fig. 4). One possibility for a future 
project would be to perform a controlled comparison of 
the enhancement approaches in order to investigate the 
relative merits of each.
As both capture enrichment and targeted amplification 
techniques are continuing to advance rapidly it is prema-
ture to declare one technique to be better than the other 
for all applications. However, since capture enrichment 
arrays already can scale to over one million probes it is 
likely that this will be the best approach for very large scale 
targeting. It should also be noted that capture techniques 
will likely work better in cases with highly-degraded DNA 
where PCR often fails to work [36]. Similarly, since tar-
geted amplification can provide lower levels of detection 
than random amplification against large genomic back-
grounds with all else being equal, a lasting niche for this 
technique is also likely for applications targeting a mod-
erate number of regions where sensitivity at low levels is 
vital. Future increases in NGS sequencing read lengths 
will be matched with larger amplicon targets, increasing 
the information content of targeted amplification even 
if the primer limits stay constant. A reasonable specula-
tion is that there will continue to be multiple methods for 
enhancing sequencing of desired regions.
The targeted amplification technique demonstrated 
here can be aimed at multiple levels of resolution. 
Amplicons can be selected to identify organisms, as 
shown here, to identify genes of interest (e.g. known 
virulence and/or anti-microbial resistance factors), or 
to identify SNPs of interest. For example, it would be 
possible to create an AmpliSeq™ panel that specifically 
targeted key genes or sufficient SNPs to achieve a speci-
fied level of phylogenetic resolution for a set of microbial 
species, up to the limit of the maximum allowed number 
of primer pairs for the AmpliSeq™ product. This means 
that if we designed an AmpliSeq™ panel to cover enough 
phylogenetically informative SNPs by ensuring that the 
SNPs on predicted amplicons are sufficient to recapitu-
late the phylogeny based on all SNPs or whole genome 
alignments, we should get accurate genotyping and fine 
level phylogenetic classification even at very low concen-
trations of the target. It would even be possible to mix 
amplicons that query organisms, genes, and SNPs in the 








Time Cost/Sample Sensitivity Pros Cons
~5 hours Low High Fast processing,high sensitivity
Mutations in primer regions may cause FNs;
limits on number of amplicons possible




Possibility that some beads may be
missing in any given aliquot; potential




Potential inconsistent sample circulation
on array leading to FP/FN issues;
possible probe synthesis errors
Fig. 4 Relative comparison of different target enrichment methods. Targeted amplification and capture tradeoffs include time, cost, sensitivity, and 
scalability. Actual values will vary depending on sample type, details of targeting, and vendor-specific parameters
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Conclusions
Our pilot study of a targeted amplification panel focused 
on detecting several biothreat agents against a human DNA 
background demonstrated that confident species deter-
mination could be made at least 2 orders of magnitude of 
spike-in level below that of an unbiased library preparation. 
Owing to the design of the primers in the targeted amplifi-
cation panel, all reads from those amplicons are guaranteed 
to be informative at the species-resolution level. (Since vari-
ations in targeted organisms could cause individual primers 
to fail, we designed multiple highly-discriminating ampli-
cons to provide redundancy.) This contrasts to the unbi-
ased sequencing, where any reads mapping to the pathogen 
come from random locations, many of which are common 
to multiple species at higher taxonomic levels of resolution. 
Thus, the use of targeted amplification on a bench-top NGS 
platform provides a workable approach to confident and 
information-rich identification of a set of known pathogens 
from a complex sample when alternatives such as culturing 
or ultra-deep NGS are not feasible options.
Although we demonstrated our approach using a relatively 
small biothreat agent panel of 467 amplicon targets, the tar-
geted amplification technique could obviously be extended 
to other applications such as human or animal health, food 
safety, vaccine or biological product safety, contamination 
monitoring for manufacturing processes, or any application 
where it is important to know whether a set of known patho-
gens are present. It should be clear that targeting highly-dis-
criminating regions of a whole genome provides much more 
resolution power than amplifying and sequencing only the 
16S rRNA gene, although that process still remains a viable 
choice for performing a broad census of bacteria present; 
including some that may not yet have whole genomes avail-
able. Finally, although AmpliSeq™ is designed for use on Ion 
platforms, it is possible that it may be adapted for use with 
other sequencing technologies or alternative solutions may 
soon become available. Additionally, we have not tested the 
efficacy of the much larger AmpliSeq™ panels that can be 
supported by the current product.
Methods
Sample preparation
Samples were created in accordance with the manufactur-
ers’ recommendations for nucleic acid mass. Briefly, a base 
mix of Bacillus anthracis (Sterne), Yersinia pestis (Harbin), 
Francisella tularensis (LVS) and Burkholderia pseudomal-
lei (strain 9) genomic DNA (gDNA) were created such that 
the number of genome equivalents (GE) of each gDNA 
was 2× the final concentration of the 1e6 Spike mix (refer 
to Table  3). Ten nanograms (3000 GE) of human gDNA 
(Clonetech Laboratories; Mountain View, CA, USA) and 
10,000 GE of Thermotoga maritima strain MSB8 gDNA 
were added in amounts that were constant for each sample. 
T. maritima (a deep sea vent thermophile) was used here 
as an amplification control. Final sample volumes were 
20 µL. Samples were given designations based on the path-
ogen GEs spiked as follows: (1e6), (1e5), (1e4), (1e3), and 
(1e2). Pathogen spike-ins of 10 and 1 (1e1Amp, 1e0Amp) 
GE were also sequenced for the AmpliSeq™ libraries, with 
T. maritima at 10,000 GE or at the same 10 or 1 GE as the 
pathogens (1e1Amp_1e1Tmar, 1e0Amp_1e0Tmar). Copy 
numbers calculations for all spike-in organisms were based 
on the published genome and plasmid sizes in base pairs 
using NCBI accession numbers. The relevant accession 
numbers are as follows: B. anthracis NC_007530 (chromo-
some), NC_007322 (pXO1); F. tularensis NC_007880.1; 
Y. pestis NC_003143.1 (chromosome), NC_003132.1 
(pPCP1), NC_003131.1 (pPCD1), and NC_003134.1 
(pMT1); and B. pseudomallei NC_006350.1 (chromosome 
1) and NC_006351.1 (chromosome 2).
Library preparation and sequencing
AmpliSeq™ libraries were constructed with the Ion 
AmpliSeq™ library protocol and the following param-
eters: 2× primer mix, 6 µL of sample and 16 PCR cycles. 
Fragment libraries were constructed by following the 
suggested Ion PGM protocol and 6  µL of sample. All 
libraries were quality checked using the Agilent Bio-
Analyzer and quantitated using the Ion Library Quan-
titation Kit. Template was diluted to target 10–30  % 
enriched beads and clonally amplified using Ion PGM 
OT2 400 kit. Enriched beads were sequenced using 
the Ion PGM 400 Sequencing kit on an Ion 318™ chip 
at default instrument parameters. Each library was 
sequenced separately. Sequence run metrics are sum-
marized in Additional file 9: Table S1.
AmpliSeq™ panel design
A total of 9799 organism-specific amplicons created 
using custom software [6] were submitted to Life Tech-
nologies for down-selection and primer design using the 
Ion AmpliSeq™ strategy and the Ion AmpliSeq™ soft-
ware. All amplicons were from genomic regions of the 
study organisms that maximally distinguish them at the 
species level from all other microbial organisms with 
genomes publically available at the time of design. Fol-
lowing several iterative rounds of primer optimization 
and removal of overlapping amplicons, a panel of 467 
primer pairs was chosen for the pilot panel (Table  3). 
Amplicon sequences are available upon request. Primer 
information is not supplied by Life Technologies.
Bioinformatic analysis
Reference mapping
Sequence read mapping was performed using CLC 
Genomics Workbench v6.5 (CLC Inc, Aarhus, Denmark). 
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CLC Reference Mapper was run with default set-
tings (Insertion cost  =  3, Deletion cost  =  3, Mismatch 
cost  =  2, Length fraction  =  0.5 and similarity frac-
tion  =  0.8). Mapping of all sequence reads was per-
formed against the amplicon sequences that comprise the 
current panel (Table 3) and/or the available NCBI refer-
ence genome for the spike in organisms.
Taxonomic classification of sequence reads
Sequence reads were trimmed and quality filtered prior 
to analysis using LMAT [37]. LMAT uses a custom k-mer 
(sequence strings of length k) database of all draft and fin-
ished microbial genomes to classify sequence reads. Each 
read is mapped to the genome(s) to which it best cor-
responds, and then a score is computed to indicate the 
confidence for each mapped genome being present. Data 
were visualized using MEGAN [38]. For comparisons 
between samples, taxa were reported for which the mini-
mum read score averaged across reads was ≥1 and there 
were at least 50 reads. Additionally, read counts were nor-
malized as a fraction of the total reads in that run.
Availability of supporting data
Supporting data may be available upon request.
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